Untoward Effects in the Practice of Therapeutic Hypothermia: A Literature Update
Received Date: Dec 27, 2017 / Accepted Date: Jan 12, 2018 / Published Date: Jan 18, 2018
Out-of-hospital cardiac arrests (OHCA) is the plague of the modern day and therapeutic hypothermia (TH) is launched to be a remedy against this. TH is practised mainly in the treatment of adult cardiac arrest and neonatal hypoxic-ischemic encephalopathy. Despite the improved benefits of mild TH, there are commonly overlooked complications associated during management. TH may cause an increase in insulin resistance and a reduction in insulin levels which result in hyperglycemia. Studies showed a significantly increased incidence of meningitis, pneumonia and wound infections. Hypothermia was also reportedly associated with increased blood loss and transfusions. In addition, electrolyte abnormalities such as hypokalaemia, hypomagnesaemia, hypophosphatemia, hypo- and hyperglycaemia have been described during TH. The procedure has also been shown to incite mild metabolic acidosis. This article reviews the current literature to provide systematic data regarding adverse and untoward effects attributed to the procedure of TH in the emergency setting.
Keywords: Cardiac arrest; Therapeutic hypothermia; Adverse effects; Side effects; Targeted temperature management
Annually, there are 356,500 out-of-hospital cardiac arrests (OHCA) in the US, with a median survival rate of 12% . Neurologic injury is the most common cause of death in patients with OHCA and contributes to the mortality of in-hospital cardiac arrest . In the post-resuscitative period, therapeutic hypothermia (TH) is thought to mitigate neurologic reperfusioninjury by decreasing cerebral oxygen consumptionand biochemical damage . TH was postulated to offer an extended therapeutic window to restore the integrity of circulation, with the brain maintained in a protective, hypometabolic state.
The promising idea of ‘human refrigeration’ was advocated first for the management of traumatic brain injury (TBI) and brain tumours by Fay in the 1940s who reported its application in 124 cases and alsoinvented one of the earliest ‘cooling blankets’ .
TH has been historically classified into: mild (34.5-36.5°C), moderate (34.5-32°C), marked (28-32°C) and profound hypothermia (<28°C) [5,6]. The administration of ‘mild TH’ has been shown to improve neurological outcomes and can prevent severe brain damage after OHCA [3,7]. In this context, induced hypothermia isevaluated in three steps: induction, maintenance and rewarming, and each phase produces several changes in normal physiology.
Hypothermia induction should be started as soon as possible to minimize neurologic damage. Infusing cold fluids, e.g., Ringer’s lactate >25 mL/kg at 4°C, is the easiest and most effective method for inducing hypothermia . Mild cooling was shown to be beneficial without many of the feared side effects. Nonetheless, TH requires an intensive care unit setting with protocolized implementation and close monitoring . It is likely that both survivors of arrest by itself and with the addition of TH procedure increase risk of complications from the hypothermia .
Substantial amount of literature data are available although there is a need to culminate these in a systematic and orderly fashion to guide monitoring the patients to avoid these in the procedure. This article reviews the current literature to provide systematic data regarding adverse and untoward effects attributed to the procedure of TH in the emergency setting.
Side/Adverse Effects/Complications Attributed to TH
Decrement in body temperature virtually affects all biological processes. Therefore, hypothermia can cause serious complications (Table 1). Although many respond to standard measures, some may end up with important morbidity and mortality. MacLaren et al. compared the incidences of adverse events and predictors of good versus poor neurological recovery after TH in a review of medical records of 91 patients who received TH for ≥ 6 h . They reported that common adverse events were hypoglycemia (99%), shivering (84.6%), bradycardia (58.2%), electrolyte abnormalities (up to 91.2%), acute kidney injury (52.8%), infection (48.4%), and coagulopathy (40.7%).
|Organ system||Adverse effects||Specific measures|
Prolonged action potential duration
J (Osborn) waves, prolonged PR, QRS, and QT intervals
Bedside monitoring of the rhythm, right heart filling, vena cava inferior index etc. (via Swan-Ganz catheter)
Beware of fluid depletion
Dysrhythmias are typically managed conventionally
|Pulmonary||Neurologic pulmonary edema
|Pneumonia incidence is not increased if TH Suctioning, head elevation, sedation breaks reduce ventilator associated pneumonia incidences|
|Infections||Suppression of the immune system,
|Cultures, prophylactic antibiotics, and removal of unnecessary catheters may decrease the incidence of infection.
Extra caution must be exercised to prevent bedsores and monitor any catheter insertion sites closely
|Hematological||Low platelet count,
Increased blood loss and transfusions with surgery, Coagulopathy
|Close monitoring is warranted.
Analyses may be masked if performed after rewarming
|Renal||Diuresis, Renal tubular dysfunction, Reduced creatinine clearance Depletion of electrolytes||Returns to normal after rewarming|
|Fluid and electrolyte disorders||Hypokalemia, Hypomagnesemia, Hypophosphatemia, hypo- and hyperglycemia||Frequent measurement and repletion of deficient serum magnesium and other electrolytes|
|Acid-base||Increased serum lactate Ketonemia, Metabolic acidosis|
|Endocrine effects||Hyperglycemia, Hypoinsulinemia||Although still debated, tight control of blood glucose might be beneficial|
|Gastrointestinal||Ileus, Delayed gastric emptying||Early enteral nutrition is feasible in those without ileus|
|Liver Function and Drug Metabolism||Reduced P450 activity Reduced plasma clearance of drugs
Propofol, fentanyl, and acetaminophen are commonly associated with ADRs
|Reversed after rewarming
Adding a bolus as opposed to increasing the drip rate is advised to achieve more sedation
Judicious use and close monitoring of drugs
|Neurological||Seizures EEG abnormalities / Malignant EEG||Decreased incidence with a target temperature of 32°C
EEG monitoring to prevent seizures.
|Others-miscellaneous||Shivering||Buspirone (PO) and/or meperidine (IV), skin warming work for treatment|
Table 1: Distribution of adverse effects and/or complications attributed to TH.
Induction of mild TH causes sinus tachycardia in order to increase oxygenation of the vital organs. Compartmental shifting from peripheral vasoconstriction to the core vasculature follows. Vasoconstrictionrelated increase in systemic vascular resistance ensues which, in turn, result in an increase in mean arterial pressure concomitant with a drop in heart rate and cardiac output [12,13]. Hypothermia has a positive inotropic effect which results from improved left ventricular filling due to bradycardia. Heart rate is mostly reduced up to 40 to 45 beats/ min at 32°C which does not warrant any specific treatment per se . Jacobshagen et al. reported hemodynamic data from 200 survivors of arrest who underwent mild TH and showed increased contractility in the failing human myocardium, due to augmented sensitivity to calcium which suggested that mild TH stabilizes hemodynamics .
Hypothermia is known to decrease spontaneous repolarization of cardiac myocytes and prolongs action potential duration and impulse conduction which is translated to ECG abnormalities as J (Osborn) waves concurrent with prolonged PR, QRS, and QT intervals. Fortunately, J waves arerarely seen in mild (32°C-34°C) hypothermia . Accordingly, the most frequent ECG changes in patients receiving mild TH are prolonged PR intervals, widening of the QRS complex, and increased QT interval [15,16].
Augmented venous return leads to an overt activation o fatrial natriuretic peptide and decreased levels of antidiuretic hormone creating the so-called ‘cold diuresis’ . Therefore, patients treated with TH is recommended to receive fluid boluses with bedside monitoring of right heart filling, vena cava inferior index etc. to beware of fluid depletion.
• In the range of 32°C to 35°C, decreases in heart rate, blood pressure, and cardiac output are seen along with an increase in central venous pressure.
• Around 32°C to 33°C, there is an increased risk of cardiac dysrhythmias, and J waves, first-degree heart block, and prolonged QT .
• Below 28°C, ventricular dysrhythmias may first appear but are mostly encountered in case of more severe hypothermia.
The risk of dysrhythmias generally does not increase at temperatures more than 30°C [13,18]. Dysrhythmias have typically been manageable with standard interventions and in some researches of mild-tomoderate TH, they were not any more common than in normothermic settings [19,20]. Bernard et al. pointed out that TH was not associated with a substantial proarrhythmic effect in the group treated with 33°C .
It is shown that hypothermia may cause coronary vasoconstriction especially during induction phase (PSJT, MGJSG) [21,22]. This may result in acute myocardial ischemia and finally, ventricular fibrillation or ventricular tachycardia. Hypothermia causes an elevation in endothelial-derived release factor, a vasodilator to prevent vasospasm. On the other hand, magnesium deficiency has been shown to be an inciting event for coronary spasm. Another interesting point is whether these patients suffered from cardiovascular complications related to coronary interventions after resuscitation and TH. Chisholm et al. identified 68 unconscious patients between 2010 and 2013, who were resuscitated after OHCA and underwent acute percutaneous coronary intervention (PCI) with stent implantation and immediate TH, and followed these for 30 days via Western Denmark Heart Registry . The authors observed only one stent thrombosis in this cohort and concluded that PCI with stent implantation could be performed with acceptable safety in these patients.
It is recommended to manage the patient treated with mild TH with close monitoring via Swan-Ganz catheter if shock is suspected. It is of utmost importance to ensure proper mixed venous oxygenation to provide necessary hemodynamic support. Indeed, TH may provide beneficial effects in patients with cardiogenic shock, as the profound bradycardia may act as a beta-blockade to reduce work and therefore oxygen demand of the heart .
It is sometimes hard to discern untoward effects of TH from those caused by the disease of the patient itself and metabolic complications of these. For example, we know that up to one-third of intubated neurologic patients may develop acute respiratory distress syndrome (ARDS) . Neurologic pulmonary edema is also common in patients treated with TH . Interestingly, the reported incidence of ARDS in patients undergoing even prolonged TH is half of that for normothermic population . Reports cited that increased incidence of pneumonia was reported only when hypothermia is maintained for longer than 48 hours [28,29]. Some researchers pointed out that the barbiturate use may be a significant risk factor . On the other hand, the most recent Cochrane systematic review of TH for TBI found that TH was associated with an increased incidence of pneumonia, but that this was not statistically significant for trials with good allocation concealment .
Solutions suggested to reduce the risks include strict implementation of protocols known to reduce ventilator associated pneumonia (vigorous suctioning, head elevation, sedation breaks), minimizing the use of barbiturates, and keeping the duration of hypothermia as short as possible .
Increased rates of bacteremia were encountered after prophylactic hypothermia in the operative setting . Other studies showed a significantly increased incidence of meningitis . Likewise, pneumonia and wound infections risks are significantly increased. In a large, multicenter, international registry of patients receiving mild TH, pneumonia and sepsis were not associated with increased mortality, and there was an inverse relationship between infection and mortality . On the other hand, a sample of patients undergoing prolonged TH has been shown to exhibit a significantly lower rate of infection in the hypothermia group compared to controls . Culture of the bodily fluid, use of prophylactic antibiotics, and removal of unnecessary catheters may decrease the incidence of infection .
TH is reported to boost the risk of wound infections; therefore, extra caution must be exercised to prevent bedsores and monitor any catheter insertion sites closely . Wound infection rates are found to be higher because of local vasoconstriction and tissue hypoxia, as well as suppression of the immune system [35-37]. To reduce the risk of infections augmented by TH, Polderman and colleagues used both antibiotic prophylaxis and selective decontamination of the digestive tract, which may have had some protective effect .
Effects on hematologic function
“The more hypothermic the patient is, the more likely hemorrhage will occur” . Some researchers declared that TH causes a decrease in platelet count and function which is reversible with rewarming [38-41], although hemoglobin levels remain the same [27,42,43]. Specifically, platelet function may be decreased to less than 35°C, while the coagulation cascade is affected at below 33°C . Note that technically the adverse effects on coagulation studies in the clinical setting may be masked if analyses are performed on rewarmed blood .
There is ongoing debate on whether significant prolongation of activated partial thromboplastin time (aPTT) can be expected or not [34,43]. A meta-analysis of high-quality clinical trials of TH for TBI showed that overall, PTT was only slightly increased with TH . One study of TH on neonatal infants with hypoxic-ischemic encephalopathy reported higher PT, lower platelets, and more requirements for platelet and plasma transfusion in the hypothermia group .
In the surgical setting, hypothermia was reportedly associated with increased blood loss and transfusions . Coagulopathy may be of more concern in trauma where there is more likely to be ongoing hemorrhage . On the other hand, large clinical trials in patients with subarachnoid hemorrhage, TBI, and stroke did not report an increased risk of bleeding with hypothermia.
There seems to be an increased risk for coagulopathy in the treatment with TH and thus the procedure warrants close monitoring for this. The risks of coagulopathy are to be weighed against the advantages of TH. For instance, a reversible period of coagulopathy may be an acceptable risk if the treatment increase the chances of survival in an otherwise fatal condition.
Known effects of hypothermia include urinary diuresis, renal tubular dysfunction, reduced creatinine clearance and increased excretion of electrolytes which result in depletion of important elements [17,31,48-51]. Zane et al. recently published data on the differences in vancomycin disposition in pediatric patients following cardiac arrest treated with either TH or normothermia . They noted that children receiving hypothermia and/or with decreased renal function had lower vancomycin clearances based on a retrospectively fitted twocompartment model in children who experience cardiac arrest. Metz et al. pointed out that serum creatinine levels had returned to normal in all participants after 24 hours of rewarming .
Fluid and electrolyte disorders
Electrolyte disorders are common in TH, especially in the inductionphase. Electrolyte abnormalities such as hypokalemia, hypomagnesemia, hypophosphatemia, hypo- and hyperglycemia have been described during TH [11,53-56]. TH typically causes a decrease in almost all electrolyte except sodium: magnesium, potassium, phosphate, and calcium which can be translated into many clinical conditions [49,57,58]. Of note, a reduction in magnesium level may impair neurological functions .
Potassium levels decline with hypothermia and and hyperpotassemia may be encountered if a patient is rewarmed rapidly. Serum sodium levels areusually unaffected [42,43]. Higher prevalences of hypernatremia and hypokalemia were reported by Shiozaki et al. in patients undergoing TH in one study . Thus, frequent measurement and repletion of deficit serum magnesium and other electrolytes should be instituted.
Electrolytes have been recommended to be maintained in the high normal range during TH , although it is necessary to replace only proven losses of most electrolytes, e.g., potassium. Reports indicated that patients who had only documented losses replaced remained normokalemic upon rewarming and thus dysrhythmias are bewared .
Hypothermia has been shown to increase serum lactate levels (5-7 mmol/L) and augment the synthesis of glycerol, free fatty acids, ketonic acids and lactate, leading to mild metabolic acidosis . On the other hand, a respiratory compensation occurs and pH measured in the hypothermic state will be higher than that measured at 37°C, parallel with a decrease in PaCO2 (17). During the induction of TH procedure, patients receiving mild TH had an average pH decrease from 7.37 to 7.31 . Hypothermia decreases both oxygen consumption and the production of carbon dioxide, thereby diminishing metabolic demands (+8% per °C drop in core temperature) .
Endocrine effects and glycemic control
MTH commonly induces hyperglycemia due to insulin sensitivity because of decreased insulin secretion by the pancreas not only resulting in increased insulin requirements but also may further increase the risk of infection [13,15,60]. During TH procedure, hyperglycemia can be seen with temperatures in the mildly hypothermic range . Several studies showed benefit to tight control [61-64] whereas some other trials and a meta-analysis found no benefit and potential harm [65-67] especially in patients with TBI. Hypothermic patients may require more insulin administration, which seems to be associated with increased mortality .
Glycemic variability may play a role in morbidity regardless of the blood glucose levels . Therefore, optimal glycemic control in TH warrants more studies and changes with the nature of trauma. Nevertheless, significant differences in glycemia or insulin requirements were not reported in trials comparing patients undergoing hypothermia to controls monitored closely [34,42,43].
Shivering occurs with a decrease in core temperature below 35.5°C and ceases at temperatures less than 30°C; it increases metabolic rate and oxygen consumption . The process is viewed as the body’s adaptive mechanism against cooling. It may increase metabolic heat production along with oxygen consumption by 50% to 400%. Data have shown that oxygen consumption is linearly related to shivering. However, one study found that hypoxia reduced oxygen consumption more in cold than in thermoneutral environments and concluded that the decrease in metabolic rate was in part due to the hypoxic suppression on shivering . Of note, shivering increase hemodynamic stress through tachycardia, vasoconstriction, and hypertension. Some studies indicated that shivering may be an important surrogate for good neurologic outcome .
Most researchers do not favour shivering in patients survived resuscitation via TH. A study by Mokhtarani, et al. found that treatment with buspirone 30 mg prior to initiation of mild TH decreased the shivering threshold 2°C to 4°C while working synergistically with meperidine . Skin warming and intermittent administration of IV meperidine 25 to 75 mg can help achieve adequate suppression of shivering. Likewise, IV magnesium sulfate 2 mg, IV dexmedetomidine 0.2 to 1.5 mg/kg/h, IV propofol, and IV vecuronium 0.1 mg/kg attenuate shivering .
TH is known to precipitate or worsen ileus and delay gastric emptying. Furthermore, ileus is common and thus gastric decompression may be beneficial. Incidence of stress ulcers are also boosted and standard care measures thereof should be instituted . Dobak et al. conducted a comparison study of small sample size focusing on feeding in patients with spontaneous intracerebral hemorrhage and treated with mild TH . They reported that three patients (50%) with mild TH experienced high gastric residuals prior to prokinetic agents, and one (16.6%) had mild ileus. No gastrointestinalrelated adverse events were reported in those treated with mild TH. They also concluded that early enteral nutrition is feasible, although delayed early enteral nutrition initiation, high gastric residuals, and less early enteral nutrition provision are common in the clinical practice.
Liver function and drug metabolism
TH has the potential to alter physiological processes and thus several classes of drugs may become affected by the process. Functional activity of cytochrome P450 system is reduced in patients treated with TH . A systematic review found that P450 activity was reduced between 7% and 22% per C below 37°C . Reactions dependent to these enzymes can be inhibited, which means that plasma levels of drugs will mostly be higher than expected and prolonged effects can be seen. Fortunately, these are effects which are usually reversed after rewarming [17,51].
TH modify drug function via changes in drug absorption, metabolism, and excretion, resulting in possible underperformance of the drug or reduced plasma clearance with potential adverse drug reactions (ADRs) and toxicity. The essential mechanism of altered metabolism is diminution of cytochrome P 450 enzyme activity secondary to reduced hepatic blood flow and decreased gastrointestinal absorption . Clearance of commonly used medications such as vasopressors, opiates, sedatives, volatile anesthetics, neuromuscular blockers, and phenytoin was shown to be reduced with TH in studies . Since this can increase drug potency, adding a bolus as opposed to increasing the drip rate may be advised in cases that require more sedation.
Witcher, et al. have recently conducted a retrospective chart review of 229 patients admitted to an intensive care unit after cardiac arrest and treated with TH . There were 670 possible ADRs i.e., an average of 3 for each patient treated with TH- and 69 probable ADRs identified. Of the 670 possibleADRs, propofol, fentanyl, and acetaminophen were the most common drugs associated with ADRs, while fentanyl, insulin, and propofol were the most common drugs associated with a probable ADR. There is a need for judicious use and close monitoring of drugs in the setting of TH until recommendations on dosing are available to helpprevent ADRs.
Neurological disorders: seizures, EEG features
Seizures are also encountered in survivors of CA treated with mild TH up to 12% to 44% [76,77]. Seizures after CA are associated with poor outcome  with prolonged seizures likely contributing to secondary brain injury. A trial from Lopez-de-Sa, et al. found a decrease in seizure incidence with a target temperature of 32°C and may yield better protection than cooling at 34°C (1 vs. 11) . EEG monitoring may help prevent this complication in victims of arrest undergoing mild TH. Kim et al. suggested that increased interictal epileptiform discharges with rewarming in post-CA patients undergoing TH may suggest poor prognosis . There was a trend toward the emergence of interictal epileptiform discharges upon rewarming and mortality, but it was not statistically significant.
Westhall et al. reported that highly malignant EEG after rewarming reliably predicted poor outcome in half of patients without false predictions . An isolated finding of a single malignant feature did not predict poor outcome whereas a benign EEG was highly predictive of a good outcome.
TH may render patients with successful recovery from CA situations prone to a myriad of complications or untoward effects on virtually all organ systems of the human being. For example, adverse drug reactions may be encountered more commonly following use of medications which mandate close monitoring and necessary measures be taken. Potentially beneficial effects of TH on neuronal recovery must be balanced against the adverse effects, such as infections, impaired blood coagulation, electrolyte disorders, and hyperglycemia.
- Members W, Lloyd-Jones D, Adams R (2009) Heart disease and stroke statistics-2009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 21-181.
- Coppler PJ, Marill KA, Okonkwo DO, Shutter LA, Dezfulian C, et al. (2016) Concordance of Brain and Core Temperature in Comatose Patients After Cardiac Arrest. Ther Hypothermia Temp Manag 6: 194-197.
- Hypothermia after Cardiac Arrest Study Group (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiacarrest. N Engl J Med 346: 549-556.
- Fay T (1940) Observations on prolonged human refrigeration. N Y State J Med 40: 1351-1354.
- Tisherman SA, Rodriguez A, Safar P (1999) Therapeutic hypothermia in traumatology. Surg Clin North Am 79: 1269-1289.
- Andresen M, Gazmuri JT, Marín A, Regueira T, Rovegno M, et al. (2015) Therapeutic hypothermia for acute brain injuries. Scand J Trauma Resusc Emerg Med 5: 23-42.
- Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, et al. (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with inducedhypothermia. N Engl J Med 346: 557-563.
- Kliegel A, Losert H, Sterz F, Kliegel M, Holzer M, et al. (2005) Cold simple intravenous infusions preceding special endovascular cooling for faster induction of mild hypothermia after cardiac arrest-a feasibility study. Resuscitation 64: 347-351.
- Karnatovskaia LV, Wartenberg KE, Freeman WD (2014) Therapeutic Hypothermia for Neuroprotection: History, Mechanisms, Risks, and Clinical Applications. Neurohospitalist 4: 153-163.
- Arrich J, Holzer M, Herkner H, Mullner M (2012) Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev CD004128.
- MacLaren R, Gallagher J, Shin J, Varnado S, Nguyen L, et al. (2014) Assessment of adverse events and predictors of neurological recovery after therapeutic hypothermia. Ann Pharmacother 48: 17-25.
- Giraud R, Siegenthaler N, Bendjelid K (2013) Cardiac index duringtherapeutic hypothermia: which target value is optimal? Crit Care 17: 214.
- Polderman KH (2009) Mechanisms of action, physiological effects,and complications of hypothermia. Crit Care Med 37: 186-202.
- Jacobshagen C, Pelster T, Pax A, Wiebke H, Tim S, et al. (2010) Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium. Clin Res Cardiol 99: 267-276.
- Polderman KH (2004) Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality.Part 1: Indications and evidence. Intensive Care Med 30: 556-575.
- Lebiedz P, Meiners J, Samol A, Kristina W, Holger R, et al. (2012) Electrocardiographic changes during therapeutic hypothermia. Resuscitation 83: 602-606.
- Kempainen RR, Brunette DD (2004) The evaluation and management of accidental hypothermia. Respir Care 49: 192-205.
- Nunnally ME, Jaeschke R, Bellingan GJ, Lacroix J, Mourvillier B, et al. (2011) Targeted temperature management in critical care: a report and recommendations from five professional societies. Crit Care Med 39: 1113-1125.
- Peterson K, Carson S, Carney N (2008) Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 25: 62-71.
- Adelson PD, Ragheb J, Kanev P, Brockmeyer D, Beers SR, et al. (2005) Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children. Neurosurgery 56: 740-754.
- Patel SJ, Tapper EB, Cutlip DE (2012) Clinical pearls regarding Prinzmetal’s angina complicated by cardiac arrest-management during therapeutic hypothermia. Int J Cardiol 159: 55-57.
- Mazie`res G, Souteyrand G, Eschalier R, Gue´rin R, Motreff PA, et al. (2012) cardiac arrest: when recommended mild therapeutic hypothermia reveals the mechanism. Crit Care Med 40: 976-978.
- Chisholm GE, Grejs A, Thim T, Kaltoft A, Jens FL, et al. (2015) Safety of therapeutic hypothermia combined with primary percutaneous coronary intervention after out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care 4: 60-63.
- Noyes AM, Lundbye JB (2015) Managing the Complications of Mild Therapeutic Hypothermia in the Cardiac Arrest Patient. J Intensive Care Med 30: 259-269.
- Hoesch RE, Lin E, Young M, Gottesman RF, Laith A, et al. (2012) Acute lung injury in critical neurological illness. Crit Care Med 40: 587-593.
- Inamasu J, Nakatsukasa M, Mayanagi K, Miyatake S, Sugimoto K, et al. (2012) Subarachnoidhemorrhage complicated with neurogenic pulmonary edema andtakotsubo-like cardiomyopathy. Neurol Med Chir 52: 49-55.
- Seule MA, Muroi C, Mink S, Yonekawa Y, Keller E, et al. (2009) Therapeutichypothermia in patients with aneurysmal subarachnoidhemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery 64: 86-92.
- Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, et al. (2001) Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 32: 2033-2035.
- Shiozaki T, Hayakata T, Taneda M, Nakajima Y, Hashiguchi N, et al. (2001) A multicenter prospectiverandomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. Mild Hypothermia Study Group in Japan. J Neurosurg 94: 50-54.
- Sydenham E, Roberts I, Alderson P (2009) Cochrane Database Syst Rev CD001048.
- Polderman KH, Tjin Joe RT, Peerdeman SM,Vandertop WP, Girbes AR, et al. (2002) Effects of therapeutic hypothermiaon intracranial pressure and outcome in patients with severehead injury. Intensive Care Med 28: 1563-1573.
- Todd MM, Hindman BJ, Clarke WR, Torner JC, Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators (2005) Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 352: 135-145.
- Nielsen N, Sunde K, Hovdenes J, Richard RR, Sten R, et al. (2011) Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med 39: 57-64.
- Kamps M, Bisschops LA, Hoeven JGVD, Hoedemaekers CW (2011) Hypothermia does not increase the risk of infection: a case control study. Crit Care 15: 48.
- Sessler DI (2001) Complications and treatment of mild hypothermia. Anesthesiology 95: 531-543.
- Flores-Maldonado A, Medina-Escobedo CE, Rios-Rodriguez HM, Fernandez-Dominguez R (2001) Mild perioperative hypothermia and the risk of wound infection. Arch Med Res 32: 227-231.
- Kurz A, Sessler DI, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334: 1209-1215.
- Watts DD, Trask A, Soeken K, Perdue P, Dols S, et al. (1998) Hypothermic coagulopathy in trauma: effect of varying levels ofhypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 44: 846-854.
- Alderson P, Signorini D, Patil C (2008) Therapeutic hypothermia forhead injury. Cochrane Database Syst Rev 4.
- Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, et al. (1994) Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 71: 633-640.
- Valeri CR, MacGregor H, Cassidy G, Tinney R, Pompei F, et al. (1995) Effects of temperature on bleeding time and clotting time in normalmale and female volunteers. Crit Care Med 23: 698-704.
- Tokutomi T, Miyagi T, Morimoto K, Karukaya T, Shigemori M, et al. (2004) Effect of hypothermia on serum electrolyte, inflammation,coagulation, and nutritional parameters in patients with severetraumatic brain injury. Neurocrit Care 1: 171-182.
- Clifton GL, Valadka A, Zygun D, Coffey CS, Pamala D, et al. (2011) Very early hypothermiainduction in patients with severe brain injury (the National AcuteBrain Injury Study: Hypothermia II): a randomised trial. LancetNeurol 10: 131-139.
- Harris OA, Colford JM, Good MC, Matz PG (2005) The role of hypothermia in the management of severe brain injury: a meta-analysis. Arch Neurol 59: 1077-83.
- Eicher DJ, Wagner CL, Katikaneni LP, Thomas CH, Bass WT, et al. (2005) Moderatehypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol 32: 18-24.
- Sessler DI (1997) Mild perioperative hypothermia. N Engl J Med 336: 1730-1737.
- Finkelstein RA, Alam HB (2010) Induced hypothermia for trauma: current research and practice. J Intensive Care Med 25: 205-226.
- Polderman KH, Girbes AR, Peerdeman SM, Vandertop WP (2001) Hypothermia. J Neurosurg 94: 853-858.
- Polderman KH, Peerdeman SM, Girbes AR (2001) Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg 94: 697-705.
- Kaufman HH, Timberlake G, Voelker J, Pait TG (1993) Medical complications of head injury. Med Clin North Am 77: 43-60.
- Metz C, Holzschuh M, Bein T, Woertgen C, Frey A, et al. (1996) Moderate hypothermia in patients with severe head injury: cerebral and extracerebral effects. J Neurosurg 85: 533-541.
- Zane NR, Reedy MD, Gastonguay MR, Himebauch AS, Ramsey Ez, et al. (2017) A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest. Pediatr Crit Care Med 18: 290-297.
- Al-Senani F, Graffagnino C, Grotta J, Saiki R, Wood D, et al. (2004) A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard™ System and Icy™catheter following cardiac arrest. Resuscitation 62: 143-150.
- Arrich J (2007) Clinical application of mild therapeutic hypothermia after cardiac arrest. Crit Care Med 35: 1041-1047.
- Nielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, et al. (2009) Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 53: 926-934.
- Xiao G, Guo Q, Shu M, Xie X, Deng J, et al. (2013) Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest: systematic review and meta-analysis. Emerg Med J 30: 91-100.
- Polderman KH, Zanten ARV, Girbes AR (2003) The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms. Intensive Care Med 29: 1202-1203.
- Aibiki M, Kawaguchi S, Maekawa N (2001) Reversible hypophosphatemia during moderate hypothermia therapy for brain-injured patients. Crit Care Med 29: 1726-1730.
- Koht A, Cane R, Cerullo LJ (1983) Serum potassium levels during prolonged hypothermia. Intensive Care Med 9: 275-277.
- Polderman KH, Herold I (2009) Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med 37: 1101-1120.
- Berghe GVD, Wouters PJ, Bouillon R, Weekers F, Verwaest C, et al. (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31: 359-366.
- Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control andmortalityin critically ill patients. JAMA 290: 2041-2047.
- Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH, et al. (2007) Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 73: 454-460.
- Wahl WL, Taddonio M, Maggio PM, Arbabi S, Hemmila MR, et al. (2008) Mean glucose values predict trauma patient mortality. Journal of Trauma and Acute Care Surgery 65: 42-47.
- Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risksof tight glucose control in critically ill adults: a meta-analysis. JAMA 300: 933-944.
- Rosa DL, Donado J, Restrepo A, Quintero AM, Luis GG, et al. (2008) Strict glycaemic control inpatients hospitalised in amixed medical and surgical intensive careunit: a randomised clinical trial. Critical Care 12: 120.
- Oddo M, Schmidt JM, Carrera E, Neeraj B, Sander EC, et al. (2008) Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36: 3233-3238.
- Krinsley JS (2008) Glycemic variability: a strong independent predictorof mortality in critically ill patients. Crit Care Med 36: 3008-3013.
- Gautier H, Bonora M, Remmers JE (1989) Effects of hypoxia on metabolic rate of conscious adult cats during cold exposure. J Appl Physiol 67: 32-38.
- Sanjeev NU, Lundbye JB (2013) The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. Resuscitation 84: 626-629.
- Mokhtarani M, Mahgoub AN, Morioka N, Doufas AG, Sessler DI, et al. (2001) Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg 93: 1233-1239.
- Dobak S, Rincon F (2016) "Cool" Topic: Feeding During Moderate Hypothermia After Intracranial HemorrhageJPEN J Parenter Enteral Nutr 41: 1125-1130.
- Zhou J, Poloyac SM (2011) The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol 7: 803-816.
- Tortorici MA, Kochanek PM, Poloyac SM (2007) Effects of hypothermiaon drug disposition, metabolism, and response: a focus ofhypothermia-mediated alterations on the cytochrome P450enzyme system. Crit Care Med 35: 2196-2204.
- Witcher R, Dzierba AL, Kim C, Smithburger PL, Kane-Gill SL, et al. (2017) Adverse drug reactions in therapeutic hypothermia after cardiac arrest. Ther Adv Drug Saf 8: 101-111.
- Rittenberger JC, Popescu A, Brenner RP, Guyette FX, Callaway CW, et al. (2012) Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia. Neurocrit Care 16: 114-122.
- Rossetti AO, Oddo M, Liaudet L, Kaplan PW (2009) Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 72: 744-749.
- Lopez-de-Sa E, Rey JR, Armada E, Pablo S, Ana VT, et al. (2012) Hypothermia in comatose survivors from out-of-hospital cardiac arrest: pilot trial comparing 2 levels of target temperature. Circulation 126: 2826-2833.
- Kim KW, Pargeon KL, Labar AS, Friedman O, Kandula PN, et al. (2017) EEG Characteristics in Cooled and Rewarmed Periods in Post-cardiac Arrest Therapeutic Hypothermia Patients. J Clin Neurophysiol 34: 381-390.
- Westhall E, Rossetti AO, Rootselaar AFV, Troels WK, Horn J, et al. (2016) Standardized EEG interpretation accurately predicts prognosis after cardiac arrest. Neurology 86: 1482-1490.
Citation: Karcioglu O, Koyuncu N (2018) Untoward Effects in the Practice of Therapeutic Hypothermia: A Literature Update. J Vasc Med Surg 6: 356. DOI: 10.4172/2329-6925.1000356
Copyright: ©2018 Karcioglu O, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 729
- [From(publication date): 0-2018 - Oct 19, 2018]
- Breakdown by view type
- HTML page views: 688
- PDF downloads: 41